T2DM and AD share several common abnormalities, including aging-related processes, high cholesterol levels, metabolic disorders, Aβ aggregation, tau protein phosphorylation, glycogen synthase kinase-3 (GSK-3) over-activation, insulin resistance and the induction of oxidative stress [12]–[15]. Here, MAPT is linked to Alzheimer disease.